Literature DB >> 23681114

Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Jean-Jacques Candelier1, Lucien Frappart, Ange Lucien Diatta, Tarik Yadaden, Mamadou-Lamine Cissé, Jean-Marie Afoutou, Jean-Yves Picard, Benoît Mennesson, Rima Slim, Karim Si-Tayeb, Philippe Coullin.   

Abstract

Trophoblast cell adhesion and migration are carefully coordinated during normal placental development. We have compared the expression of three adhesion molecules, E-cadherin, β-catenin, and Lewis x, by immunohistochemistry during normal trophoblast differentiation, and in hydatidiform moles and choriocarcinomas. Both E-cadherin and β-catenin were expressed in normal placenta cytotrophoblast, and this expression decreased with trophoblast maturation. E-cadherin was mainly localized along the contact between cytotrophoblast and syncytiotrophoblast, which indicates its role in the differentiation of the syncytial layer. Lewis x disappeared progressively during differentiation of normal villous vessels, and was expressed in molar pregnancies. Interestingly, whereas choriocarcinomas were not, or poorly, stained, invasive hydatidiform moles (invHMs) strongly expressed Lewis x in vascular structures. This observation correlated well with E-cadherin and β-catenin expression and suggests that these three markers are associated with the invasive transformation. The presence of robust endothelial structures in invHMs could also explain their ability to maintain organized villous architecture (contrary to metastatic choriocarcinomas) during their invasion of extrauterine tissues such as the lung or the brain after dissemination through the blood flow. In our hands, Lewis x appeared to be a new, reliable marker that can be used to clearly distinguish invHMs from choriocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681114     DOI: 10.1007/s00428-013-1427-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  37 in total

1.  Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication.

Authors:  P Latour; L Boutrand; N Levy; R Bernard; A Boyer; F Claustrat; G Chazot; M Boucherat; A Vandenberghe
Journal:  Clin Chem       Date:  2001-05       Impact factor: 8.327

2.  [Choriocarcinoma in Senegal: epidemiology, prognosis and prevention].

Authors:  C T Cisse; N Lo; J C Moreau; C Fall-Gaye; V Mendez; F Diadhiou
Journal:  Gynecol Obstet Fertil       Date:  2002-11

3.  Androgenetic origin of hydatidiform mole.

Authors:  T Kajii; K Ohama
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

4.  Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi.

Authors:  D Baczyk; C Dunk; B Huppertz; C Maxwell; F Reister; D Giannoulias; J C P Kingdom
Journal:  Placenta       Date:  2005-06-13       Impact factor: 3.481

5.  Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase.

Authors:  Philip R Dash; Guy St J Whitley; Laura-Jo Ayling; Alan P Johnstone; Judith E Cartwright
Journal:  Cell Signal       Date:  2005-05       Impact factor: 4.315

6.  Evidence of a limited contribution of feto-maternal interactions to trophoblast differentiation along the invasive pathway.

Authors:  F Goffin; C Munaut; A Malassiné; D Evain-Brion; F Frankenne; V Fridman; M Dubois; S Uzan; P Merviel; J-M Foidart
Journal:  Tissue Antigens       Date:  2003-08

7.  [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].

Authors:  P Couillin; N Ravisé; J M Afoutou; R Chaïbi; M Azoulay; J Hors; J F Oury; J Boué; A Boué
Journal:  Ann Genet       Date:  1987

8.  Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.

Authors:  Sharlene Murdoch; Ugljesa Djuric; Batool Mazhar; Muheiddine Seoud; Rabia Khan; Rork Kuick; Rashmi Bagga; Renate Kircheisen; Asangla Ao; Bhawna Ratti; Samir Hanash; Guy A Rouleau; Rima Slim
Journal:  Nat Genet       Date:  2006-02-05       Impact factor: 38.330

9.  Localization of stage-specific embryonic antigens in hydatidiform mole, normal placenta, and gestational choriocarcinoma.

Authors:  R S Berkowitz; O Alberti; N J Hunter; D P Goldstein; D J Anderson
Journal:  Gynecol Oncol       Date:  1985-01       Impact factor: 5.482

10.  Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000.

Authors:  Hideo Matsui; Yoshinori Iitsuka; Koji Yamazawa; Naotake Tanaka; Katsuyoshi Seki; Souei Sekiya
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  6 in total

Review 1.  The hydatidiform mole.

Authors:  Jean-Jacques Candelier
Journal:  Cell Adh Migr       Date:  2015-09-30       Impact factor: 3.405

2.  Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features.

Authors:  Estelle Dubruc; Fabienne Allias; Anne Pierre Morel; François Golfier; Alain Puisieux; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2019-03-08       Impact factor: 4.064

3.  Effect of Bisphenol A on invasion ability of human trophoblastic cell line BeWo.

Authors:  Zi-Yi Wang; Jing Lu; Yuan-Zhen Zhang; Ming Zhang; Teng Liu; Xin-Lan Qu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 4.  Understanding and management of gestational trophoblastic disease.

Authors:  Fen Ning; Houmei Hou; Abraham N Morse; Gendie E Lash
Journal:  F1000Res       Date:  2019-04-10

5.  Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.

Authors:  H Huebner; R Strick; D L Wachter; S Kehl; P L Strissel; R Schneider-Stock; A Hartner; W Rascher; L C Horn; M W Beckmann; M Ruebner; F B Fahlbusch
Journal:  J Exp Clin Cancer Res       Date:  2017-11-23

6.  Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease.

Authors:  Zoltan Szabolcsi; Amanda Demeter; Peter Kiraly; Andrea Balogh; Melissa L Wilson; Jennifer R King; Szabolcs Hetey; Zsolt Gelencser; Koji Matsuo; Beata Hargitai; Paulette Mhawech-Fauceglia; Petronella Hupuczi; Andras Szilagyi; Zoltan Papp; Lynda D Roman; Victoria K Cortessis; Nandor Gabor Than
Journal:  Biomedicines       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.